Intra-Cellular Therapies (ITCI) Short Interest Ratio & Short Volume → The Worst is Yet to Come… (From Porter & Company) (Ad) Free ITCI Stock Alerts $65.65 -0.89 (-1.34%) (As of 05:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Intra-Cellular Therapies Short Interest DataCurrent Short Interest4,550,000 sharesPrevious Short Interest3,670,000 sharesChange Vs. Previous Month+23.98%Dollar Volume Sold Short$304.12 millionShort Interest Ratio4.8 Days to CoverLast Record DateMay 15, 2024Outstanding Shares105,570,000 sharesPercentage of Shares Shorted4.31%Today's Trading Volume592,404 sharesAverage Trading Volume909,797 sharesToday's Volume Vs. Average65% Short Selling Intra-Cellular Therapies ? Sign up to receive the latest short interest report for Intra-Cellular Therapies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartITCI Short Interest Over TimeITCI Days to Cover Over TimeITCI Percentage of Float Shorted Over Time Ad Porter & CompanyThe Worst is Yet to Come…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. Intra-Cellular Therapies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20244,550,000 shares $304.12 million +24.0%N/A4.8 $66.84 4/30/20243,670,000 shares $263.54 million +2.2%N/A3.8 $71.81 4/15/20243,590,000 shares $232.49 million +3.5%N/A3.7 $64.76 3/31/20243,470,000 shares $240.12 million +4.8%N/A4.5 $69.20 3/15/20243,310,000 shares $214.42 million -10.5%N/A4.1 $64.78 2/29/20243,700,000 shares $257.22 million -4.2%N/A4.3 $69.52 Get the Latest News and Ratings for ITCI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intra-Cellular Therapies and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,860,000 shares $289.08 million -5.2%N/A4.4 $74.89 1/31/20244,070,000 shares $274.07 million +16.0%N/A4.9 $67.34 1/15/20243,510,000 shares $232.92 million -7.9%N/A3.8 $66.36 12/31/20233,810,000 shares $272.87 million +5.8%N/A4 $71.62 12/15/20233,600,000 shares $235.58 million -8.4%N/A3.9 $65.44 11/30/20233,930,000 shares $241.18 million +15.3%N/A4.5 $61.37 11/15/20233,410,000 shares $193.31 million +7.9%N/A4.1 $56.69 10/31/20233,160,000 shares $157.24 million +17.9%N/A3.9 $49.76 10/15/20232,680,000 shares $143.81 million -4.6%N/A3.9 $53.66 9/30/20232,810,000 shares $146.37 million +26.0%N/A4.3 $52.09 9/15/20232,230,000 shares $122.72 million -12.6%N/A3.5 $55.03 8/31/20232,550,000 shares $141.58 million +0.4%N/A4 $55.52 8/15/20232,540,000 shares $146.86 million +25.1%N/A4 $57.82 7/31/20232,030,000 shares $125.54 million -16.8%N/A3.1 $61.84 7/15/20232,440,000 shares $154.99 million -6.2%N/A3.4 $63.52 6/30/20232,600,000 shares $164.63 million -22.2%N/A3.5 $63.32 6/15/20233,340,000 shares $214.66 million -2.9%N/A4 $64.27 5/31/20233,440,000 shares $204.27 million -3.4%N/A4.2 $59.38 5/15/20233,560,000 shares $231.08 million +21.9%N/A4 $64.91 4/30/20232,920,000 shares $181.48 million -9.6%N/A3.3 $62.15 4/15/20233,230,000 shares $194.48 million -3.0%N/A3.9 $60.21 3/31/20233,330,000 shares $180.32 million +27.6%N/A4.1 $54.15 3/15/20232,610,000 shares $114.32 million -21.2%N/A3.9 $43.80 2/28/20233,310,000 shares $162.29 million +37.9%N/A5 $49.03 2/15/20232,400,000 shares $120 million -8.8%N/A4 $50.00 1/31/20232,630,000 shares $126.03 million +1.5%N/A4.6 $47.92 1/15/20232,590,000 shares $124.40 million -19.3%N/A4.1 $48.03 12/30/20223,210,000 shares $169.87 million +7.4%N/A5.1 $52.92 12/15/20222,990,000 shares $154.97 million +7.2%N/A4.6 $51.83 11/30/20222,790,000 shares $151.27 million -12.3%N/A4.1 $54.22 11/15/20223,180,000 shares $161.10 million -21.7%N/A4.5 $50.66 10/31/20224,060,000 shares $185.42 million +1.0%N/A5.3 $45.67 10/15/20224,020,000 shares $188.82 million -1.5%N/A5.5 $46.97 9/30/20224,080,000 shares $189.84 million +7.4%N/A5.6 $46.53“Financial tsunami is coming to America” (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here 9/15/20223,800,000 shares $192.01 million +15.5%N/A5.1 $50.53 8/31/20223,290,000 shares $165.36 million -12.0%N/A4.4 $50.26 8/15/20223,740,000 shares $196.46 million +12.0%N/A5 $52.53 7/31/20223,340,000 shares $180.76 million -10.0%N/A4.1 $54.12 7/15/20223,710,000 shares $204.98 million +1.6%N/A4.7 $55.25 6/30/20223,650,000 shares $208.34 million +1.7%N/A4.3 $57.08 6/15/20223,590,000 shares $202.94 million +15.1%8.1%4.1 $56.53 5/31/20223,120,000 shares $179.09 million -18.8%N/A3.6 $57.40 5/15/20223,840,000 shares $226.94 million +15.0%N/A4 $59.10 4/30/20223,340,000 shares $169.04 million -12.1%N/A3.5 $50.61 4/15/20223,800,000 shares $244.34 million -1.3%N/A3.8 $64.30 3/31/20223,850,000 shares $235.58 million -10.5%N/A3.7 $61.19 3/15/20224,300,000 shares $250.99 million -11.9%N/A3.3 $58.37 2/28/20224,880,000 shares $270.74 million +1.2%N/A3.9 $55.48 2/15/20224,820,000 shares $269.92 million +1.9%6.6%4 $56.00 1/31/20224,730,000 shares $224.63 million +5.6%6.5%4.3 $47.49 1/15/20224,480,000 shares $192.95 million -1.1%N/A4.3 $43.07 12/31/20214,530,000 shares $237.10 million +22.8%6.2%4.9 $52.34 12/15/20213,690,000 shares $137.30 million +2.2%5.1%5.8 $37.21 11/30/20213,610,000 shares $146.13 million -2.2%5.0%8.1 $40.48 11/15/20213,690,000 shares $148.52 million -12.4%5.1%8.5 $40.25 10/29/20214,210,000 shares $181.32 million -21.2%5.8%9.5 $43.07 10/15/20215,340,000 shares $209.86 million -7.5%7.4%12.6 $39.30 9/30/20215,770,000 shares $215.11 million -1.4%8.0%13.4 $37.28 9/15/20215,850,000 shares $195.80 million No Change8.1%12.2 $33.47 8/31/20215,850,000 shares $194.22 million +7.0%8.1%12.1 $33.20 8/13/20215,470,000 shares $158.79 million -2.5%7.5%11.2 $29.03 7/30/20215,610,000 shares $192.59 million -2.8%7.8%11.3 $34.33 7/15/20215,770,000 shares $216.43 million +11.6%8.0%11.6 $37.51 6/30/20215,170,000 shares $211.04 million -12.2%7.2%10.1 $40.82 6/15/20215,890,000 shares $255.10 million -5.9%8.2%12.3 $43.31 5/28/20216,260,000 shares $246.71 million -8.4%8.7%12.9 $39.41 5/14/20216,830,000 shares $258.58 million No ChangeN/A13 $37.86 4/30/20216,830,000 shares $235.43 million +9.5%N/A12.1 $34.47 4/15/20216,240,000 shares $201.36 million -0.5%N/A10.8 $32.27 3/31/20216,270,000 shares $203.84 million -1.1%N/A10.4 $32.51 3/15/20216,340,000 shares $231.66 million -1.4%N/A9.5 $36.54 2/26/20216,430,000 shares $229.42 million +1.3%N/A9.2 $35.68 2/12/20216,350,000 shares $247.97 million -4.8%N/A8.6 $39.05 1/29/20216,670,000 shares $214.84 million -3.5%N/A8.8 $32.21 1/15/20216,910,000 shares $235.91 million -8.7%N/A9 $34.14 12/31/20207,570,000 shares $243.91 million +11.7%N/A10 $32.22 12/15/20206,780,000 shares $171.33 million +7.8%N/A8.3 $25.27 11/30/20206,290,000 shares $157.12 million +9.0%N/A3.3 $24.98 11/15/20205,770,000 shares $154.46 million +5.5%N/A3.1 $26.77 10/30/20205,470,000 shares $131.17 million -7.3%N/A3 $23.98 10/15/20205,900,000 shares $153.11 million +0.5%N/A3.3 $25.95 9/30/20205,870,000 shares $150.62 million -12.9%N/A3.2 $25.66 9/15/20206,740,000 shares $204.56 million +26.2%N/A3.7 $30.35 8/31/20205,340,000 shares $97.29 million +7.9%N/A3.6 $18.22“Financial tsunami is coming to America” (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here 8/14/20204,950,000 shares $95.78 million +2.1%N/A6.2 $19.35 7/31/20204,850,000 shares $96.18 million -5.1%N/A5.6 $19.83 7/15/20205,110,000 shares $120.75 million -3.8%N/A5.9 $23.63 6/30/20205,310,000 shares $133.71 million +7.7%N/A6.2 $25.18 6/15/20204,930,000 shares $99.34 million +0.2%N/A5.9 $20.15 5/29/20204,920,000 shares $102.73 million -10.2%N/A5.9 $20.88 5/15/20205,480,000 shares $121.05 million +1.7%N/A6.5 $22.09 4/30/20205,390,000 shares $95.24 million +6.5%N/A6.4 $17.67 4/15/20205,060,000 shares $83.24 million No ChangeN/A5.6 $16.45 3/31/20205,060,000 shares $89.82 million +3.9%N/A3.8 $17.75 3/13/20204,869,200 shares $80.20 million +1.9%N/A6 $16.47 2/28/20204,780,000 shares $63.67 million +7.4%N/A1.7 $13.32 2/14/20204,450,000 shares $86.64 million +2.1%N/A1.5 $19.47 1/31/20204,360,000 shares $96.97 million -33.3%9.3%1.5 $22.24 1/15/20206,540,000 shares $142.31 million -21.9%14.0%2.3 $21.76 12/31/20198,370,000 shares $197.62 million -34.9%17.9%3.1 $23.61 ITCI Short Interest - Frequently Asked Questions What is Intra-Cellular Therapies' current short interest? Short interest is the volume of Intra-Cellular Therapies shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 4,550,000 shares of ITCI short. Learn More on Intra-Cellular Therapies' current short interest. What is a good short interest ratio for Intra-Cellular Therapies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ITCI shares currently have a short interest ratio of 5.0. Learn More on Intra-Cellular Therapies's short interest ratio. Which institutional investors are shorting Intra-Cellular Therapies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Intra-Cellular Therapies: Walleye Trading LLC, Jane Street Group LLC, Torno Capital LLC, HAP Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Intra-Cellular Therapies' short interest increasing or decreasing? Intra-Cellular Therapies saw a increase in short interest in May. As of May 15th, there was short interest totaling 4,550,000 shares, an increase of 24.0% from the previous total of 3,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Intra-Cellular Therapies' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Intra-Cellular Therapies: Kura Oncology, Inc. (16.27%), Ironwood Pharmaceuticals, Inc. (14.52%), Zentalis Pharmaceuticals, Inc. (26.09%), IGM Biosciences, Inc. (24.78%), Cryoport, Inc. (8.54%), Prelude Therapeutics Incorporated (2.35%), Alnylam Pharmaceuticals, Inc. (2.01%), Teva Pharmaceutical Industries Limited (1.16%), Genmab A/S (0.45%), Royalty Pharma plc (3.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Intra-Cellular Therapies stock? Short selling ITCI is an investing strategy that aims to generate trading profit from Intra-Cellular Therapies as its price is falling. ITCI shares are trading down $0.89 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intra-Cellular Therapies? A short squeeze for Intra-Cellular Therapies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ITCI, which in turn drives the price of the stock up even further. How often is Intra-Cellular Therapies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ITCI, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: KURA Short Interest Data IRWD Short Interest Data ZNTL Short Interest Data IGMS Short Interest Data CYRX Short Interest Data PRLD Short Interest Data ALNY Short Interest Data TEVA Short Interest Data GMAB Short Interest Data RPRX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ITCI) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intra-Cellular Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.